EFFICACY AND SAFETY OF LOW TO MEDIUM-DOSE VERSUS HIGH-DOSE ASPIRIN AFTER PERCUTANEOUS CORONARY INTERVENTION: EVIDENCE BEYOND THE CURRENT-OASIS 7 TRIAL

Chirag Bavishi,Vrinda Trivedi, Saurav Chatterjee,Jacqueline E. Tamis-Holland

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2016）

引用 0|浏览3

暂无评分

摘要

In the CURRENT-OASIS 7 trial, there was no significant difference in 30-day outcomes with the use of high-dose vs low-dose Aspirin in patients undergoing Percutaneous Coronary Intervention (PCI). However less is known regarding the long-term safety and efficacy of varying Aspirin doses post PCI.

查看译文

关键词

percutaneous coronary intervention,aspirin,medium-dose,high-dose,current-oasis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要